Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
暂无分享,去创建一个
A. Ureta-Vidal | F. Lemonnier | A. Gessain | O. Gout | M. Cochet | Z. Garcia | C. Pique | N. Désiré | P. Tortevoye | A. Dehée | B. Chancerel
[1] J. Lefrère,et al. Correlation between viral dna load and serum anti p19 antibody concentrationtn symptomless human T‐lymphotropic virus type‐I (HTLV‐I)‐infected individuals , 2006, International journal of cancer.
[2] Thomas D. Schmittgen,et al. Real-Time Quantitative PCR , 2002 .
[3] J. Weber,et al. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. , 2000, Blood.
[4] A. Ureta-Vidal,et al. Evidence for the Chronic in Vivo Production of Human T Cell Leukemia Virus Type I Rof and Tof Proteins from Cytotoxic T Lymphocytes Directed against Viral Peptides , 2000, The Journal of experimental medicine.
[5] W. Blattner,et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. , 1999, The Journal of infectious diseases.
[6] Y. Tanaka,et al. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. , 1999, Journal of neurovirology.
[7] I. Bièche,et al. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. , 1999, Clinical chemistry.
[8] M. Maini,et al. T-cell clonality in immune responses. , 1999, Immunology today.
[9] M. Bonneville,et al. Implication of γδ T cells in the human immune response to cytomegalovirus , 1999 .
[10] S. Izumo,et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. , 1999, Journal of neurovirology.
[11] D. Hafler,et al. Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy. , 1999, Journal of immunology.
[12] P. Gregersen,et al. Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals. , 1998, Journal of immunology.
[13] E. Sato,et al. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization , 1998, Acta Neuropathologica.
[14] A. Cossarizza,et al. Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsets. , 1998, International immunology.
[15] E. Jaffee,et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. Katlama,et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy , 1998, Nature Medicine.
[17] S. Jacobson,et al. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. , 1997, Journal of immunology.
[18] D. Taub,et al. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. , 1997, Journal of immunology.
[19] P. Kourilsky,et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. , 1997, Journal of immunology.
[20] E. Jaffe,et al. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. , 1997, The New England journal of medicine.
[21] P. Höllsberg. Pathogenesis of chronic progressive myelopathy associated with human T‐cell lymphotropic virus type I , 1997, Acta neurologica Scandinavica. Supplementum.
[22] A. Haase,et al. Human T‐lymphotropic virus type I‐associated myelopathy and tax gene expression in CD4+ T lymphocytes , 1996, Annals of neurology.
[23] S. Wain-Hobson,et al. Proliferation of HTLV-1 infected circulating cells in vivo in all asymptomatic carriers and patients with TSP/HAM. , 1996, Oncogene.
[24] P. Gregersen,et al. Oligoclonality of CD8+ T cells in health and disease: aging, infection, or immune regulation? , 1996, Human immunology.
[25] M. Dougados,et al. Spread of clonal T-cell expansions in rheumatoid arthritis patients. , 1996, Human immunology.
[26] A. Kermode,et al. High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. , 1996, Virology.
[27] U. Utz,et al. Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion , 1996, Journal of virology.
[28] S. Wain-Hobson,et al. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy , 1995, Journal of virology.
[29] F. Poccia,et al. CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons. , 1995, Journal of immunology.
[30] P. Kourilsky,et al. T-cell repertoires in healthy and diseased human tissues analysed by T-cell receptor beta-chain CDR3 size determination: evidence for oligoclonal expansions in tumours and inflammatory diseases. , 1995, Research in immunology.
[31] Y. Itoyama,et al. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis , 1994, The Journal of experimental medicine.
[32] J. Weber,et al. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously , 1994, Journal of virology.
[33] I. Elovaara,et al. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease , 1993, The Journal of experimental medicine.
[34] M. Zöller,et al. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[35] C. Bangham,et al. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. , 1992, Virology.
[36] D. Hafler,et al. T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Lal,et al. Concomitant augmentation of CD4+CD29+ helper inducer and diminution of CD4+CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II , 1992, Clinical and experimental immunology.
[38] S. Kleinman,et al. Immunologic correlates of spontaneous lymphocyte proliferation in human T-lymphotropic virus infection. , 1991, Blood.
[39] S. Kam‐Hansen,et al. Chronic progressive myelopathy associated with HTLV‐I , 1989, Neurology.
[40] Y. Itoyama,et al. Increases in helper induced T cells and activated T cells in HTLV‐I–associated myelopathy , 1989 .
[41] Y. Itoyama,et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV‐I‐associated myelopathy , 1988, Neurology.
[42] Y. Itoyama,et al. Altered subsets of peripheral blood lymphocytes in patients with HTLV‐I associated myelopathy (HAM) , 1988, Neurology.
[43] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[44] Mitsuhiro Osame,et al. HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY , 1986, The Lancet.
[45] F. Barin,et al. ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS , 1985, The Lancet.
[46] M. Yoshida,et al. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Levin,et al. HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. , 1997, Journal of neurovirology.
[48] D. Hafler,et al. HTLV-I-induced T-cell activation. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[49] Y. Itoyama,et al. Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy. , 1989, Annals of neurology.
[50] H. Towler,et al. Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera , 2022 .